EUVIMEDEUVIMED entdecken
Crossref

Pozycja lisinoprilu w leczeniu zaawansowanej niewydolności serca u pacjenta z objawową hipotensją i cechami przewodnienia

Zuzanna Karolina Wojdyńska

Choroby Serca i Naczyń · 2024

DOI: 10.5603/chsin.103121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Choroby Serca i Naczyń, 2024. Verfasst von Zuzanna Karolina Wojdyńska.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Caring of patients with heart failure requires a personalized approach to ensure the longest possible survival in the best comfort. Given the wide spectrum of symptoms experienced by patients with heart failure, it is particularly important to select the appropriate pharmacological treatment, which consists of drugs that improve prognosis and reduce symptoms. The following case concerns a 70-year-old man with advanced heart failure caused by ischemic cardiomyopathy, who complained of shortness of breath on slight exertion, edema, dizziness and falls. The patient received optimal pharmacotherapy for heart failure, including ARNI. The physical examination revealed signs of fluid retention in both the pulmonary and systemic circulation, as well as hypotension of 88/62 mmHg, with a regular sinus rhythm of approximately 60bpm. Additional tests revealed an increased level of NTproBNP 7645 pg/ml. Echocardiographic examination showed an enlarged left ventricle (51 mm), reduced left ventricular ejection fraction of 20%, dilated to 27 mm, non-respiratory inferior vena cava. To exclude significant changes in the coronary arteries, coronary angiography was performed revealing maximal stenoses of up to 40%, without restenosis in stents. Pharmacotherapy was modified, due to hypotension, ARNI was replaced by lisinopril and due to persistent fluid retention hydrochlorothiazide was added. After modifying the treatment, the blood pressure increased up to >100/60mmHg, dizziness and weakness disappeared as well as the edema, the NYHA class was reduced from III to II and the walking distance was extended. Due to good tolerance of the treatment, a single-pill with lisinopril and hydrochlorothiazide combined was introduced, which had a positive effect on the patient's compliance. Patients with heart failure are a heterogeneous group, which is why it is so important to choose the optimal pharmacotherapy, that is based on four pillars, i.e. ARNI/ACEi, beta-blocker, MRA, flozin as well as symptomatic treatment, but at the same time is tailored to the patient’s needs. In this case, hypotension leading to falls turned out to be a significant problem and replacing ARNI with lisinopril resulted in normalizing blood pressure and improvement in the patient's functioning. With the addition of hydrochlorothiazide, the symptoms resulting from overhydration also disappeared. Patients with heart failure constitute a very heterogeneous group, which is why it is so important to select the optimal therapy, that should be based on four pillars, i.e. ARNI/ACEi, beta-blocker, MRA, flozin and symptomatic treatment, but at the same time need to be tailored to the patient's needs. In this case, hypotension leading to falls turned out to be a significant problem and replacing ARNI with lisinopril resulted in normalizing blood pressure and improvement in the patient's functioning. With the addition of hydrochlorothiazide, the symptoms resulting from overhydration also disappeared.

Zitieren

APA

Wojdyńska, Z. K. (2024). Pozycja lisinoprilu w leczeniu zaawansowanej niewydolności serca u pacjenta z objawową hipotensją i cechami przewodnienia. Choroby Serca i Naczyń. https://doi.org/10.5603/chsin.103121

Vancouver

Wojdyńska ZK. Pozycja lisinoprilu w leczeniu zaawansowanej niewydolności serca u pacjenta z objawową hipotensją i cechami przewodnienia. Choroby Serca i Naczyń. 2024. doi:10.5603/chsin.103121

BibTeX
@article{Wojdyska2024,
  author = {Wojdyńska, Zuzanna Karolina},
  title = {Pozycja lisinoprilu w leczeniu zaawansowanej niewydolności serca u pacjenta z objawową hipotensją i cechami przewodnienia},
  journal = {Choroby Serca i Naczyń},
  year = {2024},
  doi = {10.5603/chsin.103121}
}
Kostenlos starten →